NSEOutcome of Board Meeting8 Jul 2026 · 8 Jul 2026, 02:37 pm
Outcome of Board Meeting
Fortis Healthcare Limited · FORTIS
✦ AI SummaryMgmt Change
Fortis Healthcare Limited has informed the Exchange regarding the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Managing Director and Chief Executive Officer) for a further period of Two years effective from March 19, 2027.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fortis Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on July 08, 2026 regarding re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Managing Director and Chief Executive Officer)
Attachments (1)
📄pdf
Download →
FORTIS_08072026143644_OUTCOMEOFBM.pdf
View document text
Fortis Healthcare Limited
Tower-A, Unitech Business Park, Block-F,
South City 1, Sector – 41, Gurgaon,
Haryana – 122 001 (India)
Tel : 0124 492 1033
Fax : 0124 492 1041
Emergency : 105010
Email : secretarial@fortishealthcare.com
Website : www.fortishealthcare.com
FHL/SEC/2026-27 July 08, 2026
The National Stock Exchange of India Ltd. BSE Limited
Scrip Symbol: FORTIS Scrip Code:532843
Sub: Outcome of the Board Meeting under Regulation 30 of Securities and Exchange Board of India (Listing
Obligations & Disclosure Requirements) Regulations, 2015
Dear Madam/Sir,
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation,
2015 (“SEBI Listing Regulations”), read with SEBI Master Circular O/49/14/14(7)2025-CFD-POD2/I/3762/2026
dated January 30, 2026, we wish to inform you that subject to the approval of shareholders, the Board of Directors of
the Company at its meeting held today i.e. July 8, 2026 have, inter-alia, considered and approved the following
matters:
- Recommend the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Managing
Director and Chief Executive Officer) of the company for a further period of Two years effective from March 19,
2027, not liable to retire by rotation;
The detailed disclosure as required under SEBI Master Circular No. O/49/14/14(7)2025-CFD-POD2/I/3762/2026
dates January 30, 2026 is enclosed as Annexure-A.
Further, Dr. Ashutosh Raghuvanshi, is not debarred from accessing the capital markets and / or restrained from holding
any position / office of director in a company pursuant to order of SEBI or any other such authority
The Board Meeting commenced at 01:00 PM IST and concluded at 02:30 PM IST.
This is for your information and record.
Thanking You,
Yours Sincerely,
For Fortis Healthcare Limited
Satyendra Chauhan
Company Secretary & Compliance Officer
M. No. A14783
Encl :a/a
FORTIS HEALTHCARE LIMITED
Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062
Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933
Fortis Healthcare Limited
Tower-A, Unitech Business Park, Block-F,
South City 1, Sector – 41, Gurgaon,
Haryana – 122 001 (India)
Tel : 0124 492 1033
Fax : 0124 492 1041
Emergency : 105010
Email : secretarial@fortishealthcare.com
Website : www.fortishealthcare.com
Annexure A
Disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 read with SEBI Master circular dated January 30, 2026
Sr. No Particulars Description
1. Reason for change viz. appointment, re- The current term of Dr. Ashutosh Raghuvanshi as
appointment, resignation, removal, death or Managing Director (designated as Managing
otherwise; Director and Chief Executive Officer) is expiring
on March 18, 2027. Considering the expertise and
his role in steering the growth of the Company, the
Board of Directors in their meeting held today
recommended his re-appointment for a further
period of Two years effective from March 19,
2027.
2. Date of appointment/re-appointment/cessation Subject to approval of the shareholders, the
(as applicable) & term of appointment/re- reappointment will be for Two years effective from
appointment March 19, 2027.
3. Brief profile (in case of appointment). Dr. Ashutosh Raghuvanshi, aged about 64 years,
holds an MBBS and an M.S. in General Surgery
from Mahatma Gandhi Institute of Medical
Sciences, Wardha, and an M.Ch. in Cardiac
Surgery from Bombay Hospital Institute of
Medical Sciences, India. He currently serves as the
Managing Director & Chief Executive Officer of
the Company. Dr. Raghuvanshi brings over 38
years of experience in the healthcare sector and has
received numerous national and international
awards in recognition of his contributions to the
industry.
Prior to joining Fortis Healthcare, Dr.
Raghuvanshi spent over 18 years with Narayana
Health, a leading healthcare chain operating over
28 hospitals, where he held several leadership
positions including as its Vice Chairman,
Managing Director and Group Chief Executive
Officer (MD & CEO).
Dr. Ashutosh Raghuvanshi's journey reflects his
multifaceted role as a distinguished cardiac
surgeon, seasoned healthcare administrator, and
visionary leader. His journey from a successful
clinician to a dynamic management professional
has significantly contributed to the success and
growth of major healthcare institutions in India.
He is closely engaged with industry bodies
including CII, FICCI, and NATHEALTH, having
served as President of NATHEALTH from 2023
to 2024.
FORTIS HEALTHCARE LIMITED
Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062
Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933
Fortis Healthcare Limited
Tower-A, Unitech Business Park, Block-F,
South City 1, Sector – 41, Gurgaon,
Haryana – 122 001 (India)
Tel : 0124 492 1033
Fax : 0124 492 1041
Emergency : 105010
Email : secretarial@fortishealthcare.com
Website : www.fortishealthcare.com
4. Disclosure of relationships between directors Dr. Raghuvanshi is not related to any of the other
(in case of appointment of a director). Directors of the Company.
FORTIS HEALTHCARE LIMITED
Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062
Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933